IRIS
FOSCHI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.134
AS - Asia 3.620
EU - Europa 3.356
SA - Sud America 878
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 112
OC - Oceania 6
Totale 17.306
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.746
IT - Italia 1.501
SG - Singapore 1.385
RU - Federazione Russa 725
BR - Brasile 690
CN - Cina 528
HK - Hong Kong 445
VN - Vietnam 442
BD - Bangladesh 404
CA - Canada 216
DE - Germania 199
FR - Francia 189
GB - Regno Unito 149
FI - Finlandia 148
NL - Olanda 142
IN - India 109
MX - Messico 73
AR - Argentina 68
AT - Austria 48
ES - Italia 42
EC - Ecuador 40
ID - Indonesia 39
JP - Giappone 37
PL - Polonia 37
ZA - Sudafrica 34
IQ - Iraq 33
SE - Svezia 30
LT - Lituania 28
CO - Colombia 27
IE - Irlanda 25
CL - Cile 21
TR - Turchia 20
AE - Emirati Arabi Uniti 18
ET - Etiopia 18
IR - Iran 17
TH - Thailandia 17
MY - Malesia 16
PK - Pakistan 16
UZ - Uzbekistan 16
CR - Costa Rica 15
SA - Arabia Saudita 15
UA - Ucraina 15
HN - Honduras 14
JM - Giamaica 13
PY - Paraguay 13
RO - Romania 13
DZ - Algeria 11
KZ - Kazakistan 10
MA - Marocco 10
VE - Venezuela 10
NI - Nicaragua 9
TN - Tunisia 9
CH - Svizzera 8
IL - Israele 8
PH - Filippine 8
TT - Trinidad e Tobago 8
GT - Guatemala 7
PR - Porto Rico 7
EG - Egitto 6
HU - Ungheria 6
NP - Nepal 6
AU - Australia 5
AZ - Azerbaigian 5
BE - Belgio 5
CZ - Repubblica Ceca 5
EE - Estonia 5
GP - Guadalupe 5
KR - Corea 5
PE - Perù 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
RS - Serbia 4
SC - Seychelles 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
CG - Congo 3
CW - ???statistics.table.value.countryCode.CW??? 3
GR - Grecia 3
KE - Kenya 3
PS - Palestinian Territory 3
AF - Afghanistan, Repubblica islamica di 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
BZ - Belize 2
DK - Danimarca 2
DM - Dominica 2
GA - Gabon 2
GD - Grenada 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 17.087
Salva come PNG Salva come JPEG
Città #
Dallas 2.423
San Jose 987
Ashburn 817
Singapore 765
Council Bluffs 755
Hong Kong 435
Santa Clara 329
New York 242
Los Angeles 222
Milan 205
Boardman 161
Ho Chi Minh City 146
The Dalles 130
Moscow 123
Lauterbourg 113
Rome 109
Hanoi 107
Beijing 100
Lappeenranta 83
Phoenix 81
Hefei 78
Orem 74
São Paulo 72
Montreal 71
Denver 63
Naples 57
San Francisco 54
Munich 52
Atlanta 48
Chicago 48
North Bergen 48
Toronto 47
Verona 41
Brooklyn 39
Frankfurt am Main 38
Mexico City 38
Bologna 36
L’Aquila 35
Helsinki 34
Turin 34
London 31
Buffalo 30
Warsaw 30
Da Nang 27
Rio de Janeiro 26
Turku 25
Charlotte 23
Shanghai 23
Stockholm 23
Tokyo 23
Boston 22
Palermo 22
Seattle 22
West Jordan 22
Chennai 21
Bari 20
Haiphong 20
Piscataway 20
Amsterdam 19
Curitiba 19
Florence 19
Benevento 18
Dublin 18
Düsseldorf 18
Guayaquil 18
Miano 18
Mumbai 18
Vilnius 18
Brasília 17
Nuremberg 17
Carrboro 16
Houston 15
Johannesburg 15
Poplar 15
Tashkent 15
Ankara 14
Catania 14
San José 14
Vienna 14
Calgary 13
Manchester 13
Miami 13
Genoa 12
Philadelphia 12
Spoltore 12
St Louis 12
City of London 11
Kitzingen 11
Madrid 11
Pescara 11
Chandler 10
Falkenstein 10
Ha Long 10
Jakarta 10
Santiago 10
Taizhou 10
Washington 10
Baghdad 9
Belo Horizonte 9
Bogotá 9
Totale 10.347
Salva come PNG Salva come JPEG
Nome #
Do antithrombotic drugs have a role in migraine prevention? A systematic review 629
Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis 613
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 374
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis 366
Coronary Artery Disease and Atherosclerosis in Other Vascular Districts: Epidemiology, Risk Factors and Atherosclerotic Plaque Features 309
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 305
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 304
Implementing Blood Biomarkers in Stroke Research and Clinical Practice 302
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years 299
Persistent progression independent of relapse activity in multiple sclerosis 237
High-Density Lipoprotein Cholesterol Levels and their impact on outcomes in acute ischemic stroke patients treated with mechanical thrombectomy 232
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage 188
Age‐Specific Differences in Inflammatory Biomarkers and Their Impact on Futile Recanalization After Mechanical Thrombectomy: An Inverse Probability Weighting Analysis 185
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 184
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 180
C-Reactive Protein elevation and subsequent atrial fibrillation detection after ischemic stroke treated with mechanical thrombectomy: an inverse probability weighting analysis 174
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 173
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 173
Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy 171
Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke 164
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 163
Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 163
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 161
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023 161
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis 153
Outcomes of Mechanical Thrombectomy in Patients With Ischemic Stroke and Heart Failure. A Systematic Review and Meta‐analysis 148
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 146
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 141
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study 138
How far are we from bringing intensive care bundle for intracerebral hemorrhage into the real-world setting? A 5-year population based-study 137
Acute stroke-like deficits associated with nonketotic hyperglycemic hyperosmolar state: an illustrative case and systematic review of literature 134
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 133
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 124
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 121
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 120
Identifying Cladribine prescription pattern in MS: an Italian multicentre study 119
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 118
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 115
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 115
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 114
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 113
Sex-based differences in inflammatory predictors of outcomes in patients undergoing mechanical thrombectomy: an inverse probability weighting analysis 113
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 110
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 108
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 107
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024) 106
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 105
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 104
Clinical characteristics and outcomes of ischemic stroke despite appropriate oral anticoagulation for atrial fibrillation: A systematic review and meta-analysis of real-world studies 104
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 103
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 103
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 103
Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials 102
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 102
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 100
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study 99
Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine 98
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 98
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study 96
The Italian Multiple Sclerosis Register Experience With Cladribine 95
Neurological abnormalities in individuals with Marfan syndrome: results from a genetically confirmed Italian cohort 94
The impact of inflammatory markers on clinical outcomes in acute ischemic stroke patients following mechanical thrombectomy: A multicentre study 93
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 92
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 91
Impact of Sex on Clinical Outcomes of Tandem Occlusion in Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy. A Propensity‐Matched Analysis 91
Neurofilament light chain and glial fibrillary acidic protein as diagnostic and prognostic biomarkers in epileptic seizures and epilepsy: A systematic review 91
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability 90
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 90
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis 89
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 88
Blood GFAP as an emerging biomarker in brain and spinal cord disorders 86
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis 86
Switch from fingolimod to ozanimod for safety or intolerance reasons 86
Annual level changes of serum neuronal and glial biomarkers in a German professional football club 85
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 85
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 85
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 84
Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment 84
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 84
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study 83
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 81
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 81
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort 80
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 80
Acute Treatment of Disabling and Nondisabling Minor Ischemic Stroke: Expert Guidance for Clinicians 79
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 79
A call for academic pragmatic clinical trials to address open questions in migraine prevention 79
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 78
Antithrombotic treatment of cervical arterial dissection: Big data needed to inform long-term management 78
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 77
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 77
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 76
Impact of Atrial Fibrillation on Outcomes in Stroke Patients with Tandem Occlusions Treated with Thrombectomy.A multicentre study 75
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 74
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 74
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke 73
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 72
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 72
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study 72
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 71
Totale 13.640
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 0 7 1 3
2022/202390 1 2 0 3 3 4 0 2 12 1 5 57
2023/2024391 6 10 16 47 22 47 3 3 3 85 63 86
2024/20252.742 106 28 195 99 229 178 292 205 629 259 264 258
2025/20269.693 277 2.307 793 1.073 564 341 1.066 464 754 772 732 550
2026/20274.379 598 958 934 1.889 0 0 0 0 0 0 0 0
Totale 17.306